IDEAS home Printed from https://ideas.repec.org/a/nat/nature/v435y2005i7040d10.1038_nature03587.html
   My bibliography  Save this article

Regulation of PDGF signalling and vascular remodelling by peroxiredoxin II

Author

Listed:
  • Min Hee Choi

    (Ewha Womans University)

  • In Kyung Lee

    (Ewha Womans University)

  • Gyung Whan Kim

    (Yonsei University College of Medicine)

  • Bang Ul Kim

    (Ewha Womans University)

  • Ying-Hao Han

    (Korea Research Institute of Bioscience and Biotechnology)

  • Dae-Yeul Yu

    (Korea Research Institute of Bioscience and Biotechnology)

  • Hye Sun Park

    (Ewha Womans University)

  • Kyung Yong Kim

    (Labfrontier Co. Ltd., KSBC building)

  • Jong Seo Lee

    (Labfrontier Co. Ltd., KSBC building)

  • Chulhee Choi

    (Ewha Womans University
    KAIST)

  • Yun Soo Bae

    (Ewha Womans University)

  • Byung In Lee

    (Yonsei University College of Medicine)

  • Sue Goo Rhee

    (National Institutes of Health)

  • Sang Won Kang

    (Ewha Womans University)

Abstract

Platelet-derived growth factor (PDGF) is a potent mitogenic and migratory factor that regulates the tyrosine phosphorylation of a variety of signalling proteins via intracellular production of H2O2 (refs 1, 2–3). Mammalian 2-Cys peroxiredoxin type II (Prx II; gene symbol Prdx2) is a cellular peroxidase that eliminates endogenous H2O2 produced in response to growth factors such as PDGF and epidermal growth factor4; however, its involvement in growth factor signalling is largely unknown. Here we show that Prx II is a negative regulator of PDGF signalling. Prx II deficiency results in increased production of H2O2, enhanced activation of PDGF receptor (PDGFR) and phospholipase Cγ1, and subsequently increased cell proliferation and migration in response to PDGF. These responses are suppressed by expression of wild-type Prx II, but not an inactive mutant. Notably, Prx II is recruited to PDGFR upon PDGF stimulation, and suppresses protein tyrosine phosphatase inactivation. Prx II also leads to the suppression of PDGFR activation in primary culture and a murine restenosis model, including PDGF-dependent neointimal thickening of vascular smooth muscle cells. These results demonstrate a localized role for endogenous H2O2 in PDGF signalling, and indicate a biological function of Prx II in cardiovascular disease.

Suggested Citation

  • Min Hee Choi & In Kyung Lee & Gyung Whan Kim & Bang Ul Kim & Ying-Hao Han & Dae-Yeul Yu & Hye Sun Park & Kyung Yong Kim & Jong Seo Lee & Chulhee Choi & Yun Soo Bae & Byung In Lee & Sue Goo Rhee & Sang, 2005. "Regulation of PDGF signalling and vascular remodelling by peroxiredoxin II," Nature, Nature, vol. 435(7040), pages 347-353, May.
  • Handle: RePEc:nat:nature:v:435:y:2005:i:7040:d:10.1038_nature03587
    DOI: 10.1038/nature03587
    as

    Download full text from publisher

    File URL: https://www.nature.com/articles/nature03587
    File Function: Abstract
    Download Restriction: Access to the full text of the articles in this series is restricted.

    File URL: https://libkey.io/10.1038/nature03587?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    As the access to this document is restricted, you may want to search for a different version of it.

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Mahdi Hajimohammadi & Maryam Khalaji Verjani, 2019. "Dill Is an Efficient Antioxidant Against ROS Specially Singlet Oxygen in the Oleic Acid Media," Biomedical Journal of Scientific & Technical Research, Biomedical Research Network+, LLC, vol. 21(5), pages 16122-16127, October.
    2. Yun Yun Yang & Xue bin Wang & Zhengyue Liu & Zhi jun Wang & Jie xiu Chen & Li peng Zhang & Li hong Gao & Zhuo Wang, 2019. "Drug-Drug Interaction Between Voriconazole and Tacrolimus in a Child Indicating the Necessity of Blood Drug Concentration Monitoring," Biomedical Journal of Scientific & Technical Research, Biomedical Research Network+, LLC, vol. 21(5), pages 16128-16130, October.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:nature:v:435:y:2005:i:7040:d:10.1038_nature03587. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.